A validated microfluidics-based LC-chip-MS/MS method for the quantitation of fluoxetine and norfluoxetine in rat serum. (Q51537199)

6 April 2018

title

A validated microfluidics-based LC-chip-MS/MS method for the quantitation of fluoxetine and norfluoxetine in rat serum. (English)

1 reference

6 April 2018

0 references

1 reference

4

1 reference

6 April 2018

Marianne Fillet

object named as

Marianne Fillet

6

0 references

author name string

Virginie Houbart

1

1 reference

6 April 2018

Anne-Catherine Servais

2

1 reference

6 April 2018

Thierry D Charlier

3

1 reference

6 April 2018

Frederic Abts

5

1 reference

6 April 2018

publication date

7 September 2012

1 reference

6 April 2018

published in

Electrophoresis

1 reference

6 April 2018

volume

33

1 reference

6 April 2018

issue

22

1 reference

6 April 2018

page(s)

3370-3379

1 reference

6 April 2018

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

cites work

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Clinical pharmacokinetics of fluoxetine

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Liquid chromatographic-mass spectrometric method for the determination of fluoxetine and norfluoxetine in human plasma: application to clinical study

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Immunoaffinity in-tube solid phase microextraction coupled with liquid chromatography-mass spectrometry for analysis of fluoxetine in serum samples

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Sensitive liquid chromatographic-tandem mass spectrometric method for the determination of fluoxetine and its primary active metabolite norfluoxetine in human plasma

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Rapid quantitation of fluoxetine and norfluoxetine in serum by micro-disc solid-phase extraction with high-performance liquid chromatography-ultraviolet absorbance detection

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Three-phase, liquid-phase microextraction combined with high performance liquid chromatography-fluorescence detection for the simultaneous determination of fluoxetine and norfluoxetine in human plasma

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Determination of fluoxetine, norfluoxetine and their enantiomers in rat plasma and brain samples by liquid chromatography with fluorescence detection.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Simultaneous determination of fluoxetine and its metabolite p-trifluoromethylphenol in human liver microsomes using a gas chromatographic-electron-capture detection procedure

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Use of the dried blood spot sampling process coupled with fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry: application to fluoxetine, norfluoxetine, reboxetine, and paroxetine analysis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Screening of citalopram, fluoxetine and their metabolites in human urine samples by gas chromatography–mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Micellar electrokinetic capillary chromatography for the determination of fluoxetine and its metabolite norfluoxetine in biological fluids.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Development and validation method for determination of fluoxetine and its main metabolite norfluoxetine by nonaqueous capillary electrophoresis in human urine

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Application of micro- and nano-HPLC to the determination and characterization of bioactive and biomarker peptides

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Microfluidic chip for peptide analysis with an integrated HPLC column, sample enrichment column, and nanoelectrospray tip.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Development of a nano-liquid chromatography on chip tandem mass spectrometry method for high-sensitivity hepcidin quantitation.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Chronic fluoxetine treatment and maternal adversity differentially alter neurobehavioral outcomes in the rat dam.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Reproductive experience alters corticosterone and CBG levels in the rat dam.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not?

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Fluoxetine kinetics and protein binding in normal and impaired renal function

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Analysis of recent pharmaceutical regulatory documents on analytical method validation

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200168

7 January 2021

Identifiers

DOI

10.1002/ELPS.201200168

1 reference

6 April 2018

1 reference

6 April 2018